Diagnostic and Prognostic Value of Circulating KRAS Mutations in Resectable Pancreatic Ductal Adenocarcinoma

被引：0
|
作者：
Hipp, J. [1 ]
Hussung, S. [2 ]
Duyster, J. [2 ]
Fichtner-Feigl, S. [1 ]
Fritsch, R. [2 ]
Wittel, U. A. [1 ]
机构：
[1] Univ Freiburg, Med Ctr, Dept Gen & Visceral Surg, Freiburg, Germany
[2] Univ Freiburg, Med Ctr, Dept Oncol, Freiburg, Germany
来源：
PANCREAS | 2018年 / 47卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：1392 / 1392
页数：1
相关论文
共 50 条
  • [31] Diagnostic value of curved multiplanar reformatted images in multislice CT for the detection of resectable pancreatic ductal adenocarcinoma
    Fukushima, Hiromichi
    Itoh, Shigeki
    Takada, Akira
    Mori, Yoshimi
    Suzuki, Kojiro
    Sawaki, Akiko
    Iwano, Shingo
    Satake, Hiroko
    Ota, Toyohiro
    Ikeda, Mitsuru
    Ishigaki, Takeo
    EUROPEAN RADIOLOGY, 2006, 16 (08) : 1709 - 1718
  • [32] Circulating tumor DNA as a prognostic indicator in resectable pancreatic ductal adenocarcinoma: A systematic review and meta-analysis
    Lee, Jee-Soo
    Rhee, Tae-Min
    Pietrasz, Daniel
    Bachet, Jean-Baptiste
    Laurent-Puig, Pierre
    Kong, Sun-Young
    Takai, Erina
    Yachida, Shinichi
    Shibata, Tatsuhiro
    Lee, Jung Woo
    Park, Hyoung-chul
    Zang, Dae Young
    Jeon, Kibum
    Lee, Jiwon
    Kim, Miyoung
    Kim, Han-Sung
    Kang, Hee Jung
    Lee, Young Kyung
    SCIENTIFIC REPORTS, 2019, 9 (1)
  • [33] Diagnostic value of curved multiplanar reformatted images in multislice CT for the detection of resectable pancreatic ductal adenocarcinoma
    Hiromichi Fukushima
    Shigeki Itoh
    Akira Takada
    Yoshimi Mori
    Kojiro Suzuki
    Akiko Sawaki
    Shingo Iwano
    Hiroko Satake
    Toyohiro Ota
    Mitsuru Ikeda
    Takeo Ishigaki
    European Radiology, 2006, 16 : 1709 - 1718
  • [34] Impact of KRAS mutations and co-mutations on clinical outcomes in Pancreatic Ductal Adenocarcinoma
    Yousef, Abdelrahman
    Yousef, Mahmoud
    Chowdhury, Saikat
    Abdilleh, Kawther
    Knafti, Mark
    Edelkamp, Paul
    Alfaro-Munoz, Kristin
    Chacko, Ray
    Peterson, Jennifer
    Smalgo, Brandon
    Wolff, Robert
    Pant, Shubham
    Lee, Michael
    Willis, Jason
    Overman, Michael
    Doss, Sudheer
    Matrisian, Lynn
    Hurd, Mark
    Synder, Rebecca
    Katz, Matthew Harold
    Wang, Huamin
    Maitra, Anirban
    Shen, John Paul
    Zhao, Dan
    MOLECULAR CANCER THERAPEUTICS, 2023, 22 (12)
  • [35] Impact of KRAS mutations and co-mutations on clinical outcomes in pancreatic ductal adenocarcinoma
    Yousef, Abdelrahman
    Yousef, Mahmoud
    Chowdhury, Saikat
    Abdilleh, Kawther
    Knafl, Mark
    Edelkamp, Paul
    Alfaro-Munoz, Kristin
    Chacko, Ray
    Peterson, Jennifer
    Smaglo, Brandon
    Wolff, Robert
    Pant, Shubham
    Lee, Michael
    Willis, Jason
    Overman, Michael
    Doss, Sudheer
    Matrisian, Lynn
    Hurd, Mark
    Snyder, Rebecca
    Katz, Matthew
    Wang, Huamin
    Maitra, Anirban
    Shen, John Paul
    Zhao, Dan
    CANCER RESEARCH, 2024, 84 (02)
  • [36] Impact of KRAS mutations and co-mutations on clinical outcomes in pancreatic ductal adenocarcinoma
    Yousef, Abdelrahman
    Yousef, Mahmoud
    Chowdhury, Saikat
    Abdilleh, Kawther
    Knafl, Mark
    Edelkamp, Paul
    Alfaro-Munoz, Kristin
    Chacko, Ray
    Peterson, Jennifer
    Smaglo, Brandon G.
    Wolff, Robert A.
    Pant, Shubham
    Lee, Michael S.
    Willis, Jason
    Overman, Michael
    Doss, Sudheer
    Matrisian, Lynn
    Hurd, Mark W.
    Snyder, Rebecca
    Katz, Matthew H. G.
    Wang, Huamin
    Maitra, Anirban
    Shen, John Paul
    Zhao, Dan
    NPJ PRECISION ONCOLOGY, 2024, 8 (01)
  • [37] Impact of KRAS mutations and co-mutations on clinical outcomes in pancreatic ductal adenocarcinoma
    Abdelrahman Yousef
    Mahmoud Yousef
    Saikat Chowdhury
    Kawther Abdilleh
    Mark Knafl
    Paul Edelkamp
    Kristin Alfaro-Munoz
    Ray Chacko
    Jennifer Peterson
    Brandon G. Smaglo
    Robert A. Wolff
    Shubham Pant
    Michael S. Lee
    Jason Willis
    Michael Overman
    Sudheer Doss
    Lynn Matrisian
    Mark W. Hurd
    Rebecca Snyder
    Matthew H. G. Katz
    Huamin Wang
    Anirban Maitra
    John Paul Shen
    Dan Zhao
    npj Precision Oncology, 8
  • [38] IDENTIFICATION OF A CIRCULATING MIRNA DIAGNOSTIC SIGNATURE IN PANCREATIC DUCTAL ADENOCARCINOMA
    Yoshida, Kazuhiro
    Toden, Shusuke
    Han, Haiyong
    Tsai, Susan
    Muhammed, Murtaza
    Celinski, Scott
    Becerra, Carlos
    Nagasaka, Takeshi
    Fujiwara, Toshiyoshi
    Evans, Douglas B.
    Hoff, Danniel V.
    Goel, Ajay
    GASTROENTEROLOGY, 2017, 152 (05) : S273 - S273
  • [39] The Poor Prognostic Factors and the Risk Classification in Patients With Resectable Pancreatic Ductal Adenocarcinoma
    Yamaki, S.
    Satoi, S.
    Yamamoto, T.
    Kosaka, H.
    Hirooka, S.
    Kotsuka, M.
    Sakaguchi, T.
    Hashimoto, Y.
    Matsui, Y.
    Sekimoto, M.
    PANCREAS, 2019, 48 (10) : 1552 - 1552
  • [40] Comparison and validation of the value of preoperative inflammation marker-based prognostic scores in resectable pancreatic ductal adenocarcinoma
    Ye, Sisi
    Bai, Li
    CANCER MANAGEMENT AND RESEARCH, 2018, 10 : 3405 - 3417
12345